IT & Data Management
CRM Software Provider Partners With Eastern European Pharma Services Company
StayinFront, Inc., a leading global provider of enterprise-wide customer relationship management (CRM) software, mobile sales force effectiveness and on-demand CRM solutions, announced today the...
Research Insight
Novartis Phase III study of Afinitor® plus Sandostatin® LAR® in patients with advanced neuroendocrine tumors showing potential benefit
A Novartis Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR® (octreotide acetate for injectable suspension) extended median progression-free survival (PFS),...
Research Insight
Afatinib (BIBW 2992*) triples progression free survival in phase III study in lung cancer patients
Boehringer Ingelheim announced today promising results from two clinical trials of its investigational cancer compound afatinib (BIBW 2992) presented at the 35 th European...
News
AstraZeneca and PoZEN received approval for VIMOVO in Europe
AstraZeneca and POZEN Inc. today announced that VIMOVO (naproxen/ esomeprazole magnesium) 500/20 mg modified-release tablets has cleared an important regulatory milestone by receiving positive...
Techno Trends
InnerCap Technologies offers Combinaton Capsule Technology
InnerCap Technologies, Inc., a drug delivery company, offers an advanced patent pending multi phased, multi compartmentalized capsular based delivery system. The system can be...
Press Releases
ImmunoGen, Inc. Announces Positive Interim Results in Randomized Clinical Trial
ImmunoGen, Inc., a biotechnology company that develops targeted antibody-based anticancer products, today announced the reporting of positive interim clinical data with trastuzumab-DM1 (T-DM1) for...
News
Bexion Pharmaceuticals Continues to Gain Support from National Cancer Institute (NCI)
Bexion Pharmaceuticals announced that it has been awarded a $1.5M Phase II Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI)....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read